Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 05, 2021

SELL
$222.0 - $252.62 $5.93 Million - $6.75 Million
-26,712 Closed
0 $0
Q4 2017

Feb 09, 2018

SELL
$100.43 - $118.09 $3.42 Million - $4.03 Million
-34,100 Reduced 56.07%
26,712 $2.92 Million
Q3 2017

Nov 13, 2017

SELL
$96.72 - $109.26 $909,168 - $1.03 Million
-9,400 Reduced 13.39%
60,812 $6.57 Million
Q2 2017

Aug 07, 2017

BUY
N/A
70,212
70,212 $7.1 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.6B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Health Invest Partners Ab Portfolio

Follow Health Invest Partners Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Health Invest Partners Ab, based on Form 13F filings with the SEC.

News

Stay updated on Health Invest Partners Ab with notifications on news.